Search

Search Results

• PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno¹, Vittorio Forte², Marco Panetta¹, Sergio Lisena¹, Giorgia Ranucci², Luigi De Marco¹, Elisabetta Greco¹, Alberto Bergamini¹, Maria Sole Chimenti¹, Paola Conigliaro¹. | ¹Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ²Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2034

  204

• PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli^1|2, Nicola Farina^1|2, Alessandro Tomelleri^1|2, Marco Matucci Cerinic^1|2, Corrado Campochiaro^1|2, Lorenzo Dagna^1|2. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2065

  173
• 

  Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  https://doi.org/10.4081/reumatismo.2024.1701

  1253

  PDF: 418

• Quality of life in systemic lupus erythematosus

  S. Rinaldi, A. Doria, F. Vescovi, S. Corbanese, L. Iaccarino, S. Della Libera, G. Perini, P.F. Gambari

  108-115

  https://doi.org/10.4081/reumatismo.2001.108

  1638

  PDF: 1464

• PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease Elena Maria Di Virgilio¹, Elisabetta Chessa², Valentina Ibba², Cosimina Matulli², Jessica Sorgia¹, Andrea Pace¹, Matteo Piga^1|2, Alberto Cauli^1|2 | ¹Università degli studi di Cagliari-Reumatologia, Cagliari, Italy; ²Struttura complessa di Reumatologia- AOU Cagliari, Cagliari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2311

  80

• Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

  A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

  121-126

  https://doi.org/10.4081/reumatismo.2006.121

  2114

  PDF: 1803

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  https://doi.org/10.4081/reumatismo.2010.215

  1371

  PDF: 885

• PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni¹, Silvia Sirotti^1|2, Georgios Filippou^1|2, Piercarlo Sarzi Puttini^1|2, Greta Pellegrino^1|2. | ¹Università degli Studi di Milano, Milano; ²IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2028

  177

• PO:26:095 | Educational online webinars of European Reference Network on rare and complex connective tissue and musculoskeletal diseases for patients, caregivers and healthcare professionals: six years' experience Emanuele Gotelli^1|2, Rosanna Campitiello^1|3, Eric Hachulla^4|5|6, Vanessa Smith^7|8|9, Joao Eurico Fonseca^10|11, Tadej Avcin^12|13, Gabriele Simonini^14|15, Silvia Aguilera¹⁶, Lisa Matthews¹⁷, Charissa Frank¹⁸, Wiebke Lautré¹⁹, Monica Testoni²⁰, Diana Marinello²⁰, Rosaria Talarico²⁰, Marta Mosca²⁰, Maurizio Cutolo^1|2. | ¹Department of Internal Medicine and Specialties, University of Genova, Genova, Italy; ²IRCCS Ospedale Policlinico San Martino, Genova, Italy; ³Department of Experimental Medicine DIMES, University of Genova, Genova, Italy; ⁴Institute for Translational Research in Inflammation INFINITE, Université de Lille, Lille, France; ⁵INSERM, Lille, France; ⁶Centre de référence des maladies autoimmunes systemiques rares du Nord et Nord-Ouest de France CeRAINO, Lille, France; ⁷Department of Internal Medicine, University of Ghent, Ghent University Hospital, Ghent, Belgium; ⁸Department of Rheumatology, University of Ghent, Ghent University Hospital, Ghent, Belgium; ⁹Unit for Molecular Immunology and Inflammation, Flemish Institute for Biotechnology, Inflammation Research Center, Ghent, Belgium; ¹⁰Centro Hospitalar Universitário Lisboa Norte EPE, Serviço de Reumatologia e Doenças Ósseas Metabólicas Lisboa Portugal; ¹¹Universidade de Lisboa, Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular João Lobo Antunes Lisboa Portugal; ¹²University Children Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia; ¹³University of Ljubljana, Department of Paediatrics, Ljubljana, Slovenia; ¹⁴University of Florence, NEUROFARBA Department, Firenze, Italy; ¹⁵Meyer Children Hospital IRCCS, Rheumatology Unit, Firenze, Italy; ¹⁶Spanish Association for Antiphospholipid Syndrome, Elche, Spain; ¹⁷Relapsing Polychondritis Awareness and Support, Worcester, United Kingdom; ¹⁸Flemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium; ¹⁹CHU Bordeaux Pellegrin, Centre de Références Maladies Auto-Immunes Systémiques Rares, Bordeaux, France; ²⁰Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2066

  158

• A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies

  R. Gutiérrez-Ramos, V. González-Díaz, M.G. Pacheco-Tovar, A. López-Luna, E. Avalos-Díaz, R. Herrera-Esparza

  296-300

  https://doi.org/10.4081/reumatismo.2008.296

  2407

  PDF: 1204

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  https://doi.org/10.4081/reumatismo.2001.46

  871

  PDF: 796

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  https://doi.org/10.4081/reumatismo.2006.50

  1047

  PDF: 2223

• PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli¹, Panagiotis Garantziotis², Sebastian Böltz², Janina Auth², Sara Bayat², Jule Taubmann², Anna-Maria Liphardt², Maria Antonietta D'Agostino¹, Christina Bergmann², Georg Schett². | ¹Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ²Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2050

  181
• 

  Histopathology of the skin in rheumatic diseases

  M.S. Chimenti, A. Di Stefani, P. Conigliaro, A. Saggini, S. Urbani, A. Giunta, M. Esposito, L. Bianchi, K. Peris, R. Perricone

  187-198

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1049

  3798

  PDF: 2070

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  https://doi.org/10.4081/reumatismo.2002.232

  1867

  PDF: 6058

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1306

  PDF: 907
• 

  Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran

  R. Assari, P. Sadeghi, A. Mirmohammadsadeghi, F. Ebadi, V. Ziaee

  189-198

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1204

  2029

  PDF: 1099

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1664

  PDF: 1155

• PO:11:172 | Not all vasculitis look the same: a difficult diagnosis Marta Arese^1|2, Miriam Perino^1|2, Sofia Aliprandi^1|2, Antonella Murgo², Maria Gerosa^1|2, Roberto Felice Caporali^1|2 | ¹UOC Reumatologia AOR San Carlo, Potenza; ²Reumatologia Clinica, ASST Gaetano Pini-CTO, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2155

  168

• PO:10:141 | A Case Study: Navigating the VEXAS Syndrome Mimickers Erika Montabone¹, Richard Borrelli¹, Nicolò Rashidy¹, Fabiana Giannoccaro², Giuseppe Guida², Federico Itri³, Renato Carignola⁴, Simone Negrini¹, Stefania Nicola¹, Luca Lo Sardo¹, Iuliana Badiu¹, Federica Corradi¹, Ambra Bonvicino⁵, Maurizio Balbi⁶, Luisa Brussino¹ | ¹SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino Torino, Italy; ²SSD Asma grave, malattie rare del polmone e fisiopatologia respiratoria, AOU San Luigi Gonzaga Orbassano, Italy; ³SCDU Medicina Interna ad indirizzo Ematologico, AOU San Luigi Gonzaga Orbassano, Italy; ⁴SCDU Medicina Interna, Scleroderma Unit, AOU San Luigi Gonzaga Orbassano, Italy; ⁵SCDU Dermatologia, Città della Salute e della Scienza di Torino Torino, Italy; ⁶SCDU Radiodiagnostica, AOU San Luigi Gonzaga, Dipartimento di Oncologia Orbassano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2309

  76

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  https://doi.org/10.4081/reumatismo.2005.262

  1316

  PDF: 1117

• PO:25:079 | Anifrolumab in refractory dermatomyositis: a case report Chiara Calabrese¹, Corrado Campochiaro^1|2, Giacomo De Luca ^1|2, Veronica Batani¹, Marco Matucci-Cerinic^1|2, Lorenzo Dagna ^1|2 | ¹Dipartimento di Reumatologia e Scienze Mediche, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milano; ²Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2190

  171
• 

  Diagnostic and prognostic role of renal histopathology in rheumatic diseases

  F. Saccon, M. Gatto, M. Larosa, F. Ometto, M. Felicetti, R. Padoan, M. Zen

  165-177

  03-10-2018

  https://doi.org/10.4081/reumatismo.2018.1064

  2636

  PDF: 1749

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  https://doi.org/10.4081/reumatismo.2010.107

  1437

  PDF: 799

• Central nervous system involvement in patients with HCV-related cryoglobulinemia: review and a case report

  D. Filippini, F. Colombo, S. Jann, R. Corneo, B. Canesi

  150-155

  https://doi.org/10.4081/reumatismo.2002.150

  1637

  PDF: 1882

• Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD

  C. Tani, M. Mosca, A. d'Ascanio, D. Versari, A. Virdis, L. Ghiadoni, S. Taddei, A. Salvetti, S. Bombardieri

  212-218

  https://doi.org/10.4081/reumatismo.2006.212

  1948

  PDF: 1449
• 

  Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus

  B. Joob, V. Wiwanitkit

  171

  24-10-2019

  https://doi.org/10.4081/reumatismo.2019.1172

  1506

  PDF: 929